DK0469440T3 - Faste orale applikationsformer, der som aktivt stof indeholder ifosamid - Google Patents

Faste orale applikationsformer, der som aktivt stof indeholder ifosamid

Info

Publication number
DK0469440T3
DK0469440T3 DK91112368.5T DK91112368T DK0469440T3 DK 0469440 T3 DK0469440 T3 DK 0469440T3 DK 91112368 T DK91112368 T DK 91112368T DK 0469440 T3 DK0469440 T3 DK 0469440T3
Authority
DK
Denmark
Prior art keywords
ifosamide
active ingredient
dosage forms
oral dosage
solid oral
Prior art date
Application number
DK91112368.5T
Other languages
English (en)
Inventor
Dieter Sauerbier
Jorgen Dr Engel
Eckhard Dr Milsmann
Klaus Dr Molge
Otto Dr Isaac
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Application granted granted Critical
Publication of DK0469440T3 publication Critical patent/DK0469440T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
DK91112368.5T 1990-08-03 1991-07-24 Faste orale applikationsformer, der som aktivt stof indeholder ifosamid DK0469440T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4024683 1990-08-03
SG181694A SG181694G (en) 1990-08-03 1994-12-30 Solid oral administration forms containing ifosfamide as active agent

Publications (1)

Publication Number Publication Date
DK0469440T3 true DK0469440T3 (da) 1994-11-14

Family

ID=25895607

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91112368.5T DK0469440T3 (da) 1990-08-03 1991-07-24 Faste orale applikationsformer, der som aktivt stof indeholder ifosamid

Country Status (33)

Country Link
US (1) US5158776A (da)
EP (1) EP0469440B1 (da)
JP (2) JP3061898B2 (da)
KR (1) KR0177170B1 (da)
CN (1) CN1046851C (da)
AR (1) AR247484A1 (da)
AT (1) ATE110261T1 (da)
AU (2) AU643309B2 (da)
BG (1) BG60900B1 (da)
CA (1) CA2048367C (da)
CZ (1) CZ280475B6 (da)
DE (2) DE59102620D1 (da)
DK (1) DK0469440T3 (da)
EG (1) EG19690A (da)
ES (1) ES2058999T3 (da)
FI (1) FI97951C (da)
HK (1) HK15695A (da)
HR (1) HRP920575B1 (da)
HU (1) HU206268B (da)
IE (1) IE66378B1 (da)
IL (1) IL99031A (da)
LT (1) LT3528B (da)
LV (1) LV10043B (da)
MC (1) MC2274A1 (da)
MX (1) MX9100441A (da)
NO (1) NO178252C (da)
NZ (1) NZ239222A (da)
PT (1) PT98532B (da)
RO (1) RO113611B1 (da)
SG (1) SG181694G (da)
SI (1) SI9111342B (da)
SK (2) SK279740B6 (da)
ZA (1) ZA916124B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0804174A4 (en) * 1993-07-21 1998-09-09 Univ Kentucky Res Found MULTI-CHAMBER HARD CAPSULES WITH CONTROLLED DELIVERY CHARACTERISTICS
ITFI970184A1 (it) * 1997-07-30 1999-01-30 Menarini Farma Ind Composizioni farmaceutiche contenenti vitamina d e calcio,loro preparazione ed uso terapeutico
DE19733305A1 (de) * 1997-08-01 1999-02-04 Asta Medica Ag Pharmazeutische Zusammensetzung enthaltend Ifosfamid und Carnitin
US6103297A (en) * 1998-01-14 2000-08-15 Matsushita Electronics Corporation Method of manufacturing cathode-ray tube
DE19826517B4 (de) * 1998-06-15 2006-03-23 Baxter Healthcare S.A. Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette
US20040253307A1 (en) * 2003-02-04 2004-12-16 Brian Hague Sugar-free oral transmucosal solid dosage forms and uses thereof
DE102005008797A1 (de) * 2005-02-25 2006-09-07 Baxter International Inc., Deerfield Trofosfamid-haltige Filmtabletten und Verfahren zu deren Herstellung
SI3091974T1 (sl) 2014-01-06 2020-08-31 Shield TX (UK) Limited Režim odmerjanja železovega trimaltola
GB201418710D0 (en) 2014-10-21 2014-12-03 Iron Therapeutics Holdings Ag Dosage regimen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5646807A (en) * 1979-09-27 1981-04-28 Japan Atom Energy Res Inst Production of composition of complex gradually releasing physiologically active substance
DE3111428A1 (de) * 1981-03-24 1982-10-07 Asta-Werke Ag, Chemische Fabrik, 4800 Bielefeld Oxazaphosphorin-4-thio-alkansulfonsaeuren und deren neutrale salze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
US4618692A (en) * 1981-09-03 1986-10-21 Asta-Werke Aktiengesellschaft 4-carbamoyloxy-oxazaphosphorins
US5019385A (en) * 1984-11-09 1991-05-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Novel lymphopine LK 2 and pharmaceutic compositions containing same
ES2038623T3 (es) * 1986-07-11 1993-08-01 Asta Medica Aktiengesellschaft Procedimiento para preparar soluciones de oxazafosforinas con estabilidad mejorada.
DE3804686A1 (de) * 1988-02-15 1989-08-24 Henkel Kgaa Arzneimittel mit einer kombination von cytostatika bzw. hormontherapeutika und phosphonoderivaten

Also Published As

Publication number Publication date
ATE110261T1 (de) 1994-09-15
SI9111342A (sl) 1998-04-30
PT98532A (pt) 1992-06-30
CS240991A3 (en) 1992-03-18
CA2048367C (en) 2000-05-23
RO113611B1 (ro) 1998-09-30
IL99031A0 (en) 1992-07-15
CA2048367A1 (en) 1992-02-04
CN1046851C (zh) 1999-12-01
DE59102620D1 (de) 1994-09-29
IL99031A (en) 1996-09-04
HRP920575A2 (en) 1995-04-30
NO913019L (no) 1992-02-04
AU643309B2 (en) 1993-11-11
JP3545300B2 (ja) 2004-07-21
CN1058715A (zh) 1992-02-19
HK15695A (en) 1995-02-10
HUT59316A (en) 1992-05-28
IE912774A1 (en) 1992-02-12
LV10043B (en) 1995-06-20
PT98532B (pt) 1999-01-29
FI97951B (fi) 1996-12-13
HRP920575B1 (en) 1999-04-30
NO178252C (no) 1996-02-21
LTIP921A (en) 1995-03-27
US5158776A (en) 1992-10-27
JP3061898B2 (ja) 2000-07-10
EP0469440B1 (de) 1994-08-24
NO913019D0 (no) 1991-08-02
SK279739B6 (sk) 1999-03-12
FI913710A0 (fi) 1991-08-02
AU4483693A (en) 1993-11-11
MC2274A1 (fr) 1993-06-23
BG60900B1 (bg) 1996-06-28
SG181694G (en) 1995-05-12
FI913710A (fi) 1992-02-04
AU649184B2 (en) 1994-05-12
NZ239222A (en) 1993-01-27
MX9100441A (es) 1992-04-01
NO178252B (no) 1995-11-13
ZA916124B (en) 1992-04-29
HU206268B (en) 1992-10-28
EP0469440A1 (de) 1992-02-05
LV10043A (lv) 1994-05-10
DE4124481A1 (de) 1992-02-06
JPH04243828A (ja) 1992-08-31
KR920003963A (ko) 1992-03-27
JP2000229860A (ja) 2000-08-22
ES2058999T3 (es) 1994-11-01
IE66378B1 (en) 1995-12-27
AU8158991A (en) 1992-02-06
SK279740B6 (sk) 1999-03-12
LT3528B (en) 1995-11-27
SI9111342B (sl) 1998-10-31
EG19690A (en) 1995-09-30
KR0177170B1 (ko) 1999-03-20
FI97951C (fi) 1997-03-25
HU912594D0 (en) 1992-01-28
AR247484A1 (es) 1995-01-31
CZ280475B6 (cs) 1996-01-17

Similar Documents

Publication Publication Date Title
ITRM920361A1 (it) Composizioni farmaceutiche contenenti un composto allilamminico quale principio attivo.
KR970006279A (ko) 약제학적 활성 성분으로서의 6-디메틸아미노메틸-1-페닐-사이클로헥산 화합물
IT8921118A0 (it) Composizione per aerosol comprendente nitroglicerina come ingrediente attivo.
NO933239D0 (no) Bioeroderbar innretning for administering av aktive ingredienser
FI925615A (fi) Stabiliserade farmaceutiska kompositioner, som innehaoller en HMG-CoA-reduktas-inhibitorfoerening
DE68901492D1 (de) Orale zusammensetzungen.
AR240225A1 (es) Composicion insecticida que comprende mas de un compuesto activo.
ATE222243T1 (de) Pharmazeutisch wirksame benzochinazolin verbindungen
IT1190824B (it) Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo
DK1140031T3 (da) Farmaceutisk sammensætning til kontrolleret frigivelse med tilidinmesylat som aktivt stof
DZ1559A1 (fr) Compositions pharmaceutiques.
DK0469440T3 (da) Faste orale applikationsformer, der som aktivt stof indeholder ifosamid
FR2698268B1 (fr) Composition photoprotectrice administrée par voie orale.
NO910874L (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
TR200001121T2 (tr) Antiromatizmal madde.
DK0668290T3 (da) Fysiologisk aktiv substans, som er i stand til at gennemtrænge biomembranen
TR27833A (tr) Antelmintik'lerin uygulanmasina mahsus ''pour-on'' formülasyonu.
DE69007956T2 (de) Antischwundadditiv enthaltender Dentalwirkstoff.
DE59008309D1 (de) Fungizide Wirkstoffkombinationen.
DE59002649D1 (de) Fungizide Wirkstoffkombinationen.
JPS545046A (en) Cephalosporin preparation for oral administration
NL7711777A (nl) Biologisch actieve tricyclische verbindingen en farmaceutische samenstellingen, welke deze verbindingen als actief bestanddeel bevatten.
EP0547224A4 (da)
DK162631C (da) Forbindelse, betegnet fr-900216, til anvendelse som terapeutisk aktivt stof, farmaceutisk praeparat indeholdende forbindelsen samt anvendelse af forbindelsen
FI933508A (fi) Bicyklopolyazamakrocyklokarboxylsyrakomplex, konjugat daerav, foerfarande foer deras framstaellning och anvaendning som radiofarmaceutiska medel